Published in J Clin Pathol on July 01, 1979
Transplantation of human tumors in nude mice. J Natl Cancer Inst (1976) 2.13
Colorimetric measurement of lactic dehydrogenase activity of body fluids. Am J Clin Pathol (1958) 1.89
Synthesis of serum albumin, prealbumin, alpha-foetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac. Nature (1970) 1.42
Clinical applications of lactate dehydrogenase isozymes: alterations in malignancy. Ann N Y Acad Sci (1968) 1.34
Developmental phase-specific alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res (1976) 1.14
Plasma protein production by human tumors xenotransplanted in nude mice. Cancer Res (1978) 1.06
Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor). Acta Pathol Microbiol Scand A (1974) 1.03
Human lactic dehydrogenase as a marker for human tumor cells grown in athymic mice. Cancer Res (1977) 0.90
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas. Acta Pathol Microbiol Scand A (1975) 0.88
Alpha-Fetoprotein in yolk sac tumor. Ann N Y Acad Sci (1975) 0.85
Regulatory controls of oncotrophoblast proteins and developmental alkaline phosphatases in cancer cells. Cancer Res (1976) 0.83
Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci (1995) 6.36
Independent photoreceptive circadian clocks throughout Drosophila. Science (1997) 5.18
Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell (1992) 5.01
The cryb mutation identifies cryptochrome as a circadian photoreceptor in Drosophila. Cell (1998) 4.81
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol (1999) 4.48
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res (1989) 4.34
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A (1995) 4.28
CRY, a Drosophila clock and light-regulated cryptochrome, is a major contributor to circadian rhythm resetting and photosensitivity. Cell (1998) 4.22
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell (1994) 4.06
A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest (1999) 3.86
Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer (1995) 3.83
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
New antibiotics, bleomycin A and B. J Antibiot (Tokyo) (1966) 3.58
K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun (1987) 3.46
Mechanical work and efficiency in level walking and running. J Physiol (1977) 3.25
Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob Agents Chemother (1982) 3.24
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene (2007) 3.11
Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell (1995) 3.01
Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res (1992) 2.89
Specification of kinetochore-forming chromatin by the histone H3 variant CENP-A. J Cell Sci (2001) 2.82
Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) (2000) 2.64
Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol (1998) 2.62
Expression of E- and P-cadherin in gastric carcinomas. Cancer Res (1991) 2.56
A new semisynthetic 7alpha-methoxycephalosporin, CS-1170: 7beta-((cyanomethyl)thio)acetamido)-7alpha-methoxy-3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid. J Antibiot (Tokyo) (1976) 2.48
Drosophila TAFII150: similarity to yeast gene TSM-1 and specific binding to core promoter DNA. Science (1994) 2.48
Ludloff's medial approach for open reduction of congenital dislocation of the hip. A 20-year follow-up. J Bone Joint Surg Br (1996) 2.45
E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A (1994) 2.35
Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum (2001) 2.28
Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res (1998) 2.27
Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer (1990) 2.22
New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation (1996) 2.14
Transplantation of human tumors in nude mice. J Natl Cancer Inst (1976) 2.13
Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res (1990) 2.13
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis (2008) 2.11
Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol (1991) 2.10
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer (2007) 2.09
Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol (1965) 2.05
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis (2010) 2.04
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Aliment Pharmacol Ther (2014) 2.03
Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology (1998) 1.97
Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc Natl Acad Sci U S A (1984) 1.95
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci U S A (1988) 1.92
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90
Double termination of the alimentary tract in females: a report of 12 cases and a literature review. J Pediatr Surg (1984) 1.90
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res (1991) 1.89
Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res (1996) 1.89
Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J Virol (1990) 1.88
An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol (1982) 1.87
Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol (1986) 1.87
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol (1993) 1.80
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res (2000) 1.80
Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. Mod Pathol (2001) 1.78
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Response evaluation criteria in solid tumors (RECIST): new guidelines. Med Pediatr Oncol (2001) 1.77
Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology (1994) 1.76
Effect of pepstatin on acid proteases. J Antibiot (Tokyo) (1971) 1.75
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet (1990) 1.75
[Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. Nihon Sanka Fujinka Gakkai Zasshi (1985) 1.74
Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol (1993) 1.74
A human condensin complex containing hCAP-C-hCAP-E and CNAP1, a homolog of Xenopus XCAP-D2, colocalizes with phosphorylated histone H3 during the early stage of mitotic chromosome condensation. Mol Cell Biol (2000) 1.73
Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett (1991) 1.73
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology (1987) 1.73
Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol (1980) 1.72
Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res (2000) 1.71
Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res (1999) 1.71
Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol (2000) 1.69
Dilatation of the intrahepatic bile ducts in congenital cystic dilatation of the common bile duct. Surgery (1971) 1.68
Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas (1997) 1.68
Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer (1982) 1.68
Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc Natl Acad Sci U S A (1998) 1.68
Pathological changes observed in the finger biopsy of patients with vibration-induced white finger. Scand J Work Environ Health (1986) 1.67
Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology (2001) 1.67
Molecular cloning of a human Ca2+-dependent cell-cell adhesion molecule homologous to mouse placental cadherin: its low expression in human placental tissues. J Cell Biol (1989) 1.66
Nestin expression in the kidney with an obstructed ureter. Kidney Int (2007) 1.66
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) (1976) 1.66
Genetic behavior of R factors in Vibrio cholerae. J Bacteriol (1972) 1.64
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer (1997) 1.64
Development of intrahepatic cholelithiasis long after primary excision of choledochal cysts. J Am Coll Surg (1996) 1.62
E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res (1996) 1.62
Melanin production in cultured albino melanocytes transfected with mouse tyrosinase cDNA. Jpn J Genet (1989) 1.61
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol (1986) 1.61
Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg (2001) 1.61
8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett (1995) 1.60
Computer-aided diagnosis for pulmonary nodules based on helical CT images. Comput Med Imaging Graph (1998) 1.60
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci (1994) 1.59
Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res (1994) 1.58
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res (1989) 1.58
Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli. FEBS Lett (1985) 1.57
Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol (1999) 1.55
Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development (1990) 1.55
Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med (1992) 1.55